Eupraxia Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.08

+0.19 (+2.76%)

As of Mar 25, 10:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +526.3% upside

Low Target $25.23

Average Target $44.34

High Target $48.95

Current Price $7.08

Current
$7.08

Target
$44.34

$25.23 $44.34 avg $48.95

Scenario Analysis

Bear Case

$25.23

256.4%

Low target

Base Case

$44.34

+526.3%

Avg target

Bull Case

$48.95

+591.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$12.86

-44.9% from high

52-Week Low

$3.96

+78.8% from low

Target vs 52W High

$44.34

+244.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%